دورية أكاديمية
Single center clinical analysis of macrophage activation syndrome complicating juvenile rheumatic diseases
| العنوان: | Single center clinical analysis of macrophage activation syndrome complicating juvenile rheumatic diseases |
|---|---|
| المؤلفون: | Shuoyin Huang, Yingying Liu, Wu Yan, Tonghao Zhang, Panpan Wang, Meifang Zhu, Xiaohua Zhang, Peng Zhou, Zhidan Fan, Haiguo Yu |
| المصدر: | Pediatric Rheumatology Online Journal, Vol 22, Iss 1, Pp 1-10 (2024) |
| بيانات النشر: | BMC, 2024. |
| سنة النشر: | 2024 |
| المجموعة: | LCC:Pediatrics LCC:Diseases of the musculoskeletal system |
| مصطلحات موضوعية: | Macrophage activation syndrome, Systemic juvenile idiopathic arthritis, Kawasaki disease, Systemic lupus erythematosus, Rheumatic diseases, Interleukin (IL)-18, Pediatrics, RJ1-570, Diseases of the musculoskeletal system, RC925-935 |
| الوصف: | Abstract Background Macrophage activation syndrome (MAS), an example of secondary hemophagocytic lymphohistiocytosis, is a potentially fatal complication of rheumatic diseases. We aimed to study the clinical and laboratory characteristics, treatment schemes, and outcomes of different rheumatic disorders associated with MAS in children. Early warning indicators of MAS have also been investigated to enable clinicians to make a prompt and accurate diagnosis. Methods Fifty-five patients with rheumatic diseases complicated by MAS were enrolled between January 2017 and December 2022. Clinical and laboratory data were collected before disease onset, at diagnosis, and after treatment with MAS, and data were compared between patients with systemic juvenile idiopathic arthritis (sJIA), Kawasaki disease (KD), and systemic lupus erythematosus (SLE). A random forest model was established to show the importance score of each variable with a significant difference. Results Most (81.8%) instances of MAS occurred during the initial diagnosis of the underlying disease. Compared to the active stage of sJIA, the platelet count, erythrocyte sedimentation rate, and fibrinogen level in sJIA-MAS were significantly decreased, whereas ferritin, ferritin/erythrocyte sedimentation rate, aspartate aminotransferase, alanine aminotransferase, lactate dehydrogenase, and D-dimer levels were significantly increased. Ferritin level, ferritin/erythrocyte sedimentation rate, and platelet count had the greatest predictive value for sJIA-MAS. The level of IL-18 in the sJIA-MAS group was significantly higher than in the active sJIA group, whereas IL-6 levels were significantly lower. Most patients with MAS were treated with methylprednisolone pulse combined with cyclosporine, and no deaths occurred. Conclusions Thrombocytopenia, ferritin levels, the ferritin/erythrocyte sedimentation rate, and elevated aspartate aminotransferase levels can predict the occurrence of MAS in patients with sJIA. Additionally, our analysis indicates that IL-18 plays an important role in the pathogenesis of MAS in sJIA-MAS. |
| نوع الوثيقة: | article |
| وصف الملف: | electronic resource |
| اللغة: | English |
| تدمد: | 1546-0096 |
| Relation: | https://doaj.org/toc/1546-0096 |
| DOI: | 10.1186/s12969-024-00991-3 |
| URL الوصول: | https://doaj.org/article/0a6ef724f8d347f0bf18268d9f5dd2bd |
| رقم الأكسشن: | edsdoj.0a6ef724f8d347f0bf18268d9f5dd2bd |
| قاعدة البيانات: | Directory of Open Access Journals |
Find this article in full text from Springer Verlag. 
Full Text Finder | تدمد: | 15460096 |
|---|---|
| DOI: | 10.1186/s12969-024-00991-3 |